Unlock stock picks and a broker-level newsfeed that powers Wall Street.
-
-
(-)
Key Executives
Key Executives Information Not Available
ContraVir Pharmaceuticals, Inc.
Profile Information Not Available
Description
Description Information Not Available
Corporate Governance
ContraVir Pharmaceuticals, Inc.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.
Upcoming Events
April 14, 2025 at 8:00 PM UTC - April 18, 2025 at 8:00 PM UTC
ContraVir Pharmaceuticals, Inc. Earnings Date
Recent Events
Recent Events Information Not Available
Related Tickers
AKTX Akari Therapeutics, Plc
1.1152
-4.68%
SION Sionna Therapeutics, Inc.
9.97
-14.13%
OVID Ovid Therapeutics Inc.
0.2816
-6.57%
ENLV Enlivex Therapeutics Ltd.
0.8880
-6.17%
CRBP Corbus Pharmaceuticals Holdings, Inc.
5.02
+2.03%
CRIS Curis, Inc.
1.2300
-7.52%
PTN Palatin Technologies, Inc.
0.5115
-3.38%
ENTO Entero Therapeutics, Inc.
0.5090
+16.48%